EP 1272190 A2 20030108 - A USE OF GALANTAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE; TARGETING THE UNDERLYING CAUSE OF THE DISEASE
Title (en)
A USE OF GALANTAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE; TARGETING THE UNDERLYING CAUSE OF THE DISEASE
Title (de)
VERWENDUNG VON GALANTAMIN ZUR BEHANDLUNG DER ALZHEIMER ERKRANKUNG; ERMITTLUNG DER DER KRANKHEIT ZUGRUNDELIEGENDEN URSACHE
Title (fr)
UTILISATION DE GALANTAMINE DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER CIBLANT LA CAUSE FONDAMENTALE DE LA MALADIE
Publication
Application
Priority
- EP 0103551 W 20010328
- US 19426200 P 20000403
Abstract (en)
[origin: WO0174364A2] Galantamine has be used in the treatment of a number of chronic diseases. Galantamine has been found to be safe and effective in the treatment of Alzheimer's disease. The therapeutic drugs, including galantamine, that have been used to date for the treatment of Alzheimer's disease were thought to provide only symptomatic relief. It has now been shown that galantamine can be used for the treatment of the underlying cause of the disease.
IPC 1-7
IPC 8 full level
A61K 31/55 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 31/55 (2013.01); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 0174364A2
Citation (third parties)
Third party :
- US 4663318 A 19870505 - DAVIS BONNIE [US]
- WO 0030446 A1 20000602 - BONNIE DAVIS [US]
- TRAYKOV L. ET AL: "3-12-24: Preliminary results of the efficacy of galanthamine on cognitive functions in patients with Alzheimer's disease (AD)", JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 150, September 1997 (1997-09-01), pages S158, XP002969083
- TRAYKOV L. ET AL: "Therapeutic efficacy of galanthamine in Alzheimers'd disease (AD) - preliminary study", EUROPEAN JOURNAL OF CLINICAL PGARMACOLOGY - ABSTRACTS OF THE 2ND CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS (EACPT), vol. 52, 17 September 1997 (1997-09-17) - 20 September 1997 (1997-09-20), pages A166/532, XP002969084
- TRAYKOV L. ET AL: "THERAPEUTIC AFFICACY OF GALANTHAMINE (NIVALIN*) ON COGNITIVE DEFICIT IN ALZHEIMER'S DISEASE", CEREBROVASCULAR DISEASE, vol. 8, January 2000 (2000-01-01), pages 23 - 27, XP002969085
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0174364 A2 20011011; WO 0174364 A3 20020516; AU 4651801 A 20011015; CA 2310990 A1 20001009; EP 1272190 A2 20030108
DOCDB simple family (application)
EP 0103551 W 20010328; AU 4651801 A 20010328; CA 2310990 A 20000627; EP 01919406 A 20010328